InsiderTrades

Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC

Accepted 2022-12-20 00:00:00 ET · period of report 2022-12-16 · accession 0001209191-22-062178 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-20 2022-12-16 ALXO Randolph Sophia Chief Medical Off, Dir M - OptEx $4.09 +46.5K 246.5K +23% +$189.9K
DM 2022-12-20 2022-12-16 ALXO Randolph Sophia Chief Medical Off, Dir M - OptEx $0.00 -46.5K 4,027 -92% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-16 M A 25,339 $4.81 271,870 D — —
2 Common Common Stock 2022-12-16 M A 8,404 $1.91 233,800 D — —
3 Common Common Stock 2022-12-16 M A 12,731 $4.08 246,531 D — —
4 Derivative Stock Option (right to buy) 2022-12-16 M D 25,339 $0.00 25,340 D $4.81 · — to 2030-04-27 25,339 Common Stock (F3) Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.
5 Derivative Stock Option (right to buy) 2022-12-16 M D 12,731 $0.00 95,175 D $4.08 · — to 2030-03-09 12,731 Common Stock (F2) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
6 Derivative Stock Option (right to buy) 2022-12-16 M D 8,404 $0.00 4,027 D $1.91 · — to 2029-09-12 8,404 Common Stock (F1) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.